High prevalence of COVID-19-associated diabetic ketoacidosis in UK secondary care.


Journal

Diabetes research and clinical practice
ISSN: 1872-8227
Titre abrégé: Diabetes Res Clin Pract
Pays: Ireland
ID NLM: 8508335

Informations de publication

Date de publication:
Aug 2020
Historique:
received: 03 06 2020
revised: 15 06 2020
accepted: 24 06 2020
pubmed: 3 7 2020
medline: 22 9 2020
entrez: 3 7 2020
Statut: ppublish

Résumé

We aim to describe the prevalence of diabetic ketoacidosis (DKA) in individuals admitted to a single centre with COVID-19. We identified 218 individuals hospitalised with COVID-19, of these four fulfilled criteria for DKA (4/218, 1.8%). We conclude DKA is common and severe in individuals hospitalised with COVID-19.

Identifiants

pubmed: 32615280
pii: S0168-8227(20)30543-X
doi: 10.1016/j.diabres.2020.108291
pmc: PMC7323680
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

108291

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Références

Acta Diabetol. 2010 Sep;47(3):193-9
pubmed: 19333547
Lancet Diabetes Endocrinol. 2020 Jun;8(6):546-550
pubmed: 32334646
Cell Metab. 2020 Jun 2;31(6):1068-1077.e3
pubmed: 32369736
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
Diabetes Res Clin Pract. 2020 Apr;162:108125
pubmed: 32224164
Diabetes Res Clin Pract. 2020 Jun;164:108219
pubmed: 32442555
Nat Rev Endocrinol. 2016 Apr;12(4):222-32
pubmed: 26893262
Nature. 2013 Mar 14;495(7440):251-4
pubmed: 23486063
N Engl J Med. 2020 Jun 18;382(25):2462-2464
pubmed: 32356625
Nat Rev Endocrinol. 2020 Jun;16(6):297-298
pubmed: 32242089
Cell. 2020 Apr 16;181(2):271-280.e8
pubmed: 32142651
Nat Rev Immunol. 2020 Jun;20(6):363-374
pubmed: 32346093
Diabetes Care. 2018 Sep;41(9):1870-1877
pubmed: 29386248
Diabetes Care. 2015 Sep;38(9):1638-42
pubmed: 26294774

Auteurs

Nina Goldman (N)

Department of Respiratory Medicine, Whipps Cross University Hospital, London, UK. Electronic address: nina.goldman@nhs.net.

Douglas Fink (D)

Department of Infectious Diseases, Whipps Cross University Hospital, London, UK.

James Cai (J)

Department of Infectious Diseases, Whipps Cross University Hospital, London, UK.

Yun-Ni Lee (YN)

Department of Diabetes and Endocrinology, Whipps Cross University Hospital, London, UK.

Zoe Davies (Z)

Department of Diabetes and Endocrinology, Whipps Cross University Hospital, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH